Bibliographic Details
| Title: |
Safety and Efficacy of First-Line Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) and Ipilimumab in Non-Small Cell Lung Cancer (NSCLC): Metastatic Non-Small Cell Lung Cancer. |
| Authors: |
Antonia, S.J.1, Gettinger, S.2, Goldman, J.3, Chow, L.Q.4, Juergens, R.5, Borghaei, H.6, Brahmer, J.R.7, Shen, Y.8, Harbison, C.8, Chen, A.C.8, Ready, N.E.9, Rizvi, N.A.10 |
| Source: |
International Journal of Radiation Oncology, Biology, Physics. Nov2014 Supplement, Vol. 90 Issue 5, pS32-S33. 1p. |
| Subjects: |
Drug efficacy, Medication safety, Lung cancer treatment, Metastasis, Ipilimumab, Monoclonal antibodies |
| Database: |
Engineering Source |
